Patel Snehal's Form 4 filing
Greenwich LifeSciences, Inc. (GLSI) · filed Mar 7, 2024
- Accession no.
- 0001493152-24-009126
- Filed
- Mar 7, 2024
- Trade date
- Mar 5, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $380.9K. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001493152-24-009164 (Mar 7, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel SnehalCIK 0001806920 | Director, Officer (CEO and CFO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 | Common Stock | PPurchaseAcquired | +30,500 | $12.49 | +$380,945 | 5,343,777 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.